List of Excipients in API norethindrone acetate and ethinyl estradiol
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing norethindrone acetate and ethinyl estradiol
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| RPK Pharmaceuticals Inc | MICROGESTIN 1/20 | norethindrone acetate and ethinyl estradiol | 53002-1549 | ACACIA | |
| RPK Pharmaceuticals Inc | MICROGESTIN 1/20 | norethindrone acetate and ethinyl estradiol | 53002-1549 | LACTOSE | |
| RPK Pharmaceuticals Inc | MICROGESTIN 1/20 | norethindrone acetate and ethinyl estradiol | 53002-1549 | MAGNESIUM STEARATE | |
| RPK Pharmaceuticals Inc | MICROGESTIN 1/20 | norethindrone acetate and ethinyl estradiol | 53002-1549 | STARCH, CORN | |
| RPK Pharmaceuticals Inc | MICROGESTIN 1/20 | norethindrone acetate and ethinyl estradiol | 53002-1549 | SUCROSE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing norethindrone acetate and ethinyl estradiol
Detailed excipient profiles for norethindrone acetate and ethinyl estradiol
Excipient focus: .ALPHA.-TOCOPHEROL
norethindrone acetate and ethinyl estradiol drug variants containing .ALPHA.-TOCOPHEROL
norethindrone acetate and ethinyl estradiol drug variants not containing .ALPHA.-TOCOPHEROL
Excipient focus: .ALPHA.-TOCOPHEROL, DL-
norethindrone acetate and ethinyl estradiol drug variants containing .ALPHA.-TOCOPHEROL, DL-
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | norethindrone acetate and ethinyl estradiol | 0378-7274 |
| Mylan Pharmaceuticals Inc | norethindrone acetate and ethinyl estradiol | 0378-7280 |
| >Company | >Ingredient | >NDC |
norethindrone acetate and ethinyl estradiol drug variants not containing .ALPHA.-TOCOPHEROL, DL-
Excipient focus: ACACIA
norethindrone acetate and ethinyl estradiol drug variants containing ACACIA
norethindrone acetate and ethinyl estradiol drug variants not containing ACACIA
Excipient focus: ALUMINUM OXIDE
norethindrone acetate and ethinyl estradiol drug variants containing ALUMINUM OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | norethindrone acetate and ethinyl estradiol | 54868-6272 |
| >Company | >Ingredient | >NDC |
norethindrone acetate and ethinyl estradiol drug variants not containing ALUMINUM OXIDE
Excipient focus: ANHYDROUS LACTOSE
norethindrone acetate and ethinyl estradiol drug variants containing ANHYDROUS LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | norethindrone acetate and ethinyl estradiol | 0378-7274 |
| Mylan Pharmaceuticals Inc | norethindrone acetate and ethinyl estradiol | 0378-7280 |
| >Company | >Ingredient | >NDC |
norethindrone acetate and ethinyl estradiol drug variants not containing ANHYDROUS LACTOSE
Excipient focus: CALCIUM STEARATE
norethindrone acetate and ethinyl estradiol drug variants containing CALCIUM STEARATE
norethindrone acetate and ethinyl estradiol drug variants not containing CALCIUM STEARATE
Excipient focus: CELLULOSE, MICROCRYSTALLINE
norethindrone acetate and ethinyl estradiol drug variants containing CELLULOSE, MICROCRYSTALLINE
norethindrone acetate and ethinyl estradiol drug variants not containing CELLULOSE, MICROCRYSTALLINE
Excipient focus: CROSCARMELLOSE SODIUM
norethindrone acetate and ethinyl estradiol drug variants containing CROSCARMELLOSE SODIUM
norethindrone acetate and ethinyl estradiol drug variants not containing CROSCARMELLOSE SODIUM
Excipient focus: D&C RED NO. 30
norethindrone acetate and ethinyl estradiol drug variants containing D&C RED NO. 30
| Company | Ingredient | NDC |
|---|---|---|
| Glenmark Pharmaceuticals Inc USA | norethindrone acetate and ethinyl estradiol | 68462-656 |
| >Company | >Ingredient | >NDC |
norethindrone acetate and ethinyl estradiol drug variants not containing D&C RED NO. 30
Excipient focus: D&C YELLOW NO. 10
norethindrone acetate and ethinyl estradiol drug variants containing D&C YELLOW NO. 10
| Company | Ingredient | NDC |
|---|---|---|
| Aurobindo Pharma Limited | norethindrone acetate and ethinyl estradiol | 65862-939 |
| Glenmark Pharmaceuticals Inc USA | norethindrone acetate and ethinyl estradiol | 68462-504 |
| >Company | >Ingredient | >NDC |
norethindrone acetate and ethinyl estradiol drug variants not containing D&C YELLOW NO. 10
Excipient focus: D&C YELLOW NO. 10 ALUMINUM LAKE
norethindrone acetate and ethinyl estradiol drug variants containing D&C YELLOW NO. 10 ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | norethindrone acetate and ethinyl estradiol | 0555-9025 |
| Teva Women's Health LLC | norethindrone acetate and ethinyl estradiol | 51285-131 |
| >Company | >Ingredient | >NDC |
norethindrone acetate and ethinyl estradiol drug variants not containing D&C YELLOW NO. 10 ALUMINUM LAKE
Excipient focus: FD&C BLUE NO. 1
norethindrone acetate and ethinyl estradiol drug variants containing FD&C BLUE NO. 1
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | norethindrone acetate and ethinyl estradiol | 0378-7274 |
| Glenmark Pharmaceuticals Inc USA | norethindrone acetate and ethinyl estradiol | 68462-504 |
| >Company | >Ingredient | >NDC |
norethindrone acetate and ethinyl estradiol drug variants not containing FD&C BLUE NO. 1
Excipient focus: FD&C RED NO. 40
norethindrone acetate and ethinyl estradiol drug variants containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | norethindrone acetate and ethinyl estradiol | 54868-6272 |
| >Company | >Ingredient | >NDC |
norethindrone acetate and ethinyl estradiol drug variants not containing FD&C RED NO. 40
Excipient focus: FD&C YELLOW NO. 6
norethindrone acetate and ethinyl estradiol drug variants containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| Glenmark Pharmaceuticals Inc USA | norethindrone acetate and ethinyl estradiol | 68462-504 |
| >Company | >Ingredient | >NDC |
norethindrone acetate and ethinyl estradiol drug variants not containing FD&C YELLOW NO. 6
Excipient focus: HYDROXYETHYL CELLULOSE
norethindrone acetate and ethinyl estradiol drug variants containing HYDROXYETHYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Nivagen Pharmaceuticals Inc | norethindrone acetate and ethinyl estradiol | 75834-130 |
| >Company | >Ingredient | >NDC |
norethindrone acetate and ethinyl estradiol drug variants not containing HYDROXYETHYL CELLULOSE
Excipient focus: HYPROMELLOSE
norethindrone acetate and ethinyl estradiol drug variants containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Nivagen Pharmaceuticals Inc | norethindrone acetate and ethinyl estradiol | 75834-130 |
| >Company | >Ingredient | >NDC |
norethindrone acetate and ethinyl estradiol drug variants not containing HYPROMELLOSE
Excipient focus: HYPROMELLOSES
norethindrone acetate and ethinyl estradiol drug variants containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| Lupin Pharmaceuticals Inc | norethindrone acetate and ethinyl estradiol | 68180-827 |
| >Company | >Ingredient | >NDC |
norethindrone acetate and ethinyl estradiol drug variants not containing HYPROMELLOSES
Excipient focus: ISOPROPYL ALCOHOL
norethindrone acetate and ethinyl estradiol drug variants containing ISOPROPYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Glenmark Pharmaceuticals Inc USA | norethindrone acetate and ethinyl estradiol | 68462-656 |
| >Company | >Ingredient | >NDC |
norethindrone acetate and ethinyl estradiol drug variants not containing ISOPROPYL ALCOHOL
Excipient focus: LACTOSE
norethindrone acetate and ethinyl estradiol drug variants containing LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| RPK Pharmaceuticals Inc | norethindrone acetate and ethinyl estradiol | 53002-1549 |
| >Company | >Ingredient | >NDC |
norethindrone acetate and ethinyl estradiol drug variants not containing LACTOSE
Excipient focus: LACTOSE MONOHYDRATE
norethindrone acetate and ethinyl estradiol drug variants containing LACTOSE MONOHYDRATE
norethindrone acetate and ethinyl estradiol drug variants not containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| RPK Pharmaceuticals Inc | norethindrone acetate and ethinyl estradiol | 53002-1549 |
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
norethindrone acetate and ethinyl estradiol drug variants containing MAGNESIUM STEARATE
norethindrone acetate and ethinyl estradiol drug variants not containing MAGNESIUM STEARATE
Excipient focus: MALTODEXTRIN
norethindrone acetate and ethinyl estradiol drug variants containing MALTODEXTRIN
norethindrone acetate and ethinyl estradiol drug variants not containing MALTODEXTRIN
Excipient focus: POLYDEXTROSE
norethindrone acetate and ethinyl estradiol drug variants containing POLYDEXTROSE
| Company | Ingredient | NDC |
|---|---|---|
| Nivagen Pharmaceuticals Inc | norethindrone acetate and ethinyl estradiol | 75834-130 |
| >Company | >Ingredient | >NDC |
norethindrone acetate and ethinyl estradiol drug variants not containing POLYDEXTROSE
Excipient focus: POLYETHYLENE GLYCOL 300
norethindrone acetate and ethinyl estradiol drug variants containing POLYETHYLENE GLYCOL 300
| Company | Ingredient | NDC |
|---|---|---|
| Nivagen Pharmaceuticals Inc | norethindrone acetate and ethinyl estradiol | 75834-130 |
| >Company | >Ingredient | >NDC |
norethindrone acetate and ethinyl estradiol drug variants not containing POLYETHYLENE GLYCOL 300
Excipient focus: POLYETHYLENE GLYCOL 400
norethindrone acetate and ethinyl estradiol drug variants containing POLYETHYLENE GLYCOL 400
| Company | Ingredient | NDC |
|---|---|---|
| Lupin Pharmaceuticals Inc | norethindrone acetate and ethinyl estradiol | 68180-827 |
| >Company | >Ingredient | >NDC |
norethindrone acetate and ethinyl estradiol drug variants not containing POLYETHYLENE GLYCOL 400
Excipient focus: POVIDONE K25
norethindrone acetate and ethinyl estradiol drug variants containing POVIDONE K25
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | norethindrone acetate and ethinyl estradiol | 0378-7274 |
| Mylan Pharmaceuticals Inc | norethindrone acetate and ethinyl estradiol | 0378-7280 |
| >Company | >Ingredient | >NDC |
norethindrone acetate and ethinyl estradiol drug variants not containing POVIDONE K25
Excipient focus: POVIDONE K30
norethindrone acetate and ethinyl estradiol drug variants containing POVIDONE K30
norethindrone acetate and ethinyl estradiol drug variants not containing POVIDONE K30
Excipient focus: SODIUM LAURYL SULFATE
norethindrone acetate and ethinyl estradiol drug variants containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | norethindrone acetate and ethinyl estradiol | 0378-7274 |
| Mylan Pharmaceuticals Inc | norethindrone acetate and ethinyl estradiol | 0378-7280 |
| >Company | >Ingredient | >NDC |
norethindrone acetate and ethinyl estradiol drug variants not containing SODIUM LAURYL SULFATE
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
norethindrone acetate and ethinyl estradiol drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | norethindrone acetate and ethinyl estradiol | 0093-3122 |
| Physicians Total Care Inc | norethindrone acetate and ethinyl estradiol | 54868-6251 |
| >Company | >Ingredient | >NDC |
norethindrone acetate and ethinyl estradiol drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
Excipient focus: STARCH, CORN
norethindrone acetate and ethinyl estradiol drug variants containing STARCH, CORN
norethindrone acetate and ethinyl estradiol drug variants not containing STARCH, CORN
Excipient focus: SUCROSE
norethindrone acetate and ethinyl estradiol drug variants containing SUCROSE
norethindrone acetate and ethinyl estradiol drug variants not containing SUCROSE
Excipient focus: TALC
norethindrone acetate and ethinyl estradiol drug variants containing TALC
norethindrone acetate and ethinyl estradiol drug variants not containing TALC
Excipient focus: TITANIUM DIOXIDE
norethindrone acetate and ethinyl estradiol drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Lupin Pharmaceuticals Inc | norethindrone acetate and ethinyl estradiol | 68180-827 |
| Nivagen Pharmaceuticals Inc | norethindrone acetate and ethinyl estradiol | 75834-130 |
| >Company | >Ingredient | >NDC |
norethindrone acetate and ethinyl estradiol drug variants not containing TITANIUM DIOXIDE
Excipient focus: TOCOPHEROL
norethindrone acetate and ethinyl estradiol drug variants containing TOCOPHEROL
| Company | Ingredient | NDC |
|---|---|---|
| Lupin Pharmaceuticals Inc | norethindrone acetate and ethinyl estradiol | 68180-827 |
| >Company | >Ingredient | >NDC |
norethindrone acetate and ethinyl estradiol drug variants not containing TOCOPHEROL
Excipient focus: TRIACETIN
norethindrone acetate and ethinyl estradiol drug variants containing TRIACETIN
| Company | Ingredient | NDC |
|---|---|---|
| Nivagen Pharmaceuticals Inc | norethindrone acetate and ethinyl estradiol | 75834-130 |
| >Company | >Ingredient | >NDC |
norethindrone acetate and ethinyl estradiol drug variants not containing TRIACETIN
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
